Z-0463-2013 Class II Terminated
Recall Details
- Product Type
- Devices
- Report Date
- December 12, 2012
- Initiation Date
- October 24, 2012
- Termination Date
- January 8, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 63 kits
Product Description
Sekisui Diagnostics, Spectrolyse PAI-1 In-Vitro Diagnostic Use for the quantitative determination of Plasminogen Activator Inhibitor Type 1 in human plasma. Catalog # 101201. Spectrolyse PAI-1 is intended for the quantitative determination of Plasminogen Activator Inhibitor Type-1 (PAI-1) activity in human plasma. The test is for in vitro diagnostic use.
Reason for Recall
Spectrolyse PAI-1 activity assay, producing lower than expected absorbance values 0 IU/ml standard reducing the slope of the standard curve requiring more frequent sample dilutions.
Distribution Pattern
Nationwide Distribution-including the states of FL, IN, NC, OH, UT, and WA.
Code Information
Lot # 120827, exp 11/27/2012